INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 342 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,050,036 | -87.5% | 33,208 | -53.4% | 0.00% | -87.5% |
| Q4 2021 | $8,428,000 | -4.0% | 71,282 | +8.9% | 0.01% | -11.1% |
| Q3 2021 | $8,781,000 | -22.9% | 65,456 | -7.0% | 0.01% | -25.0% |
| Q2 2021 | $11,391,000 | +48.9% | 70,351 | -26.2% | 0.01% | +33.3% |
| Q1 2021 | $7,648,000 | +100.8% | 95,297 | +36.1% | 0.01% | +80.0% |
| Q4 2020 | $3,809,000 | +314.5% | 70,014 | +4.0% | 0.01% | +150.0% |
| Q4 2018 | $919,000 | -80.0% | 67,322 | -58.0% | 0.00% | -77.8% |
| Q3 2018 | $4,588,000 | +60.5% | 160,303 | +53.4% | 0.01% | +50.0% |
| Q2 2018 | $2,859,000 | – | 104,505 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 752,024 | $100,884,000 | 18.57% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 420,859 | $56,458,000 | 4.40% |
| Discovery Value Fund | 922,411 | $123,741,000 | 3.63% |
| MPM BioImpact LLC | 162,620 | $21,815,000 | 3.38% |
| Ally Bridge Group (NY) LLC | 65,000 | $8,720,000 | 2.56% |
| ARK Investment Management | 6,743,556 | $904,648,000 | 2.17% |
| Integral Health Asset Management, LLC | 50,000 | $6,708,000 | 1.93% |
| Yorktown Management & Research Co Inc | 18,300 | $2,455,000 | 1.85% |
| Interchange Capital Partners, LLC | 8,191 | $1,098,000 | 1.84% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $14,950,000 | 1.76% |